Literature DB >> 13761543

Nitrogen mustard in palliation of mslignant effusions.

V B LEVISON.   

Abstract

Entities:  

Keywords:  NEOPLASMS/complications; NITROGEN MUSTARDS/therapy

Mesh:

Substances:

Year:  1961        PMID: 13761543      PMCID: PMC1953750          DOI: 10.1136/bmj.1.5233.1143

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  Chemotherapy of solid tumors with triethylene thiophosphoramide.

Authors:  J C BATEMAN
Journal:  N Engl J Med       Date:  1955-05-26       Impact factor: 91.245

2.  Direct instillation of nitrogen mustard in the management of malignant effusions.

Authors:  A S WEISBERGER
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

3.  Nitrogen mustard in the palliation of lung cancer.

Authors:  B H BASS
Journal:  Br Med J       Date:  1960-02-27

4.  Radioactive colloidal gold in the treatment of pleural and peritoneal effusions of malignant origin: review of 235 cases.

Authors:  N MACKAY
Journal:  Lancet       Date:  1957-10-19       Impact factor: 79.321

5.  Use of nitrogen mustard in treatment of serous effusions of neoplastic origin.

Authors:  A S WEISBERGER; B LEVINE; J P STORAASLI
Journal:  J Am Med Assoc       Date:  1955-12-31

6.  Comparative evaluation of radioactive colloidal gold and nitrogen mustard in the treatment of serous effusions of neoplastic origin.

Authors:  F J BONTE; J P STORAASLI; A S WEISBERGER
Journal:  Radiology       Date:  1956-07       Impact factor: 11.105

7.  Experiences with the use of radioactive colloidal gold in the treatment of cancer.

Authors:  H B WHEELER; W E JAQUES; T W BOTSFORD
Journal:  Ann Surg       Date:  1955-02       Impact factor: 12.969

8.  Radioactive isotopes in management of carcinomatosis of serous body cavities.

Authors:  E M KENT; C MOSES; W B FORD; E R KUTZ; R S GEORGE
Journal:  AMA Arch Intern Med       Date:  1954-09

9.  The use of radioactive colloidal gold (Au198) in pleural effusions and ascites associated with malignancy.

Authors:  E R KING; D W SPICER; F W DOWDA; M A BENDER; W E NOEL
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1952-09

10.  Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.

Authors:  C SELLEI; S ECKHARDT
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

View more
  1 in total

1.  The management of malignant pleural effusion.

Authors:  M L Sutton
Journal:  Postgrad Med J       Date:  1973-10       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.